Active agent in chemotherapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Tumor Cells, Cultured Bone Marrow Hepatic Artery

Organisms8

Gram-Positive Bacteria Gram-Negative Bacteria Bacteria, Anaerobic Bacteria Enterobacteriaceae Streptococcus pneumoniae Pseudomonas aeruginosa Mice, Nude

Diseases72

Breast Neoplasms Lung Neoplasms Neutropenia Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Neoplasm Recurrence, Local Ovarian Neoplasms Testicular Neoplasms Vomiting Adenocarcinoma Nausea Lymphoma, Non-Hodgkin Hodgkin Disease Colorectal Neoplasms Neoplasms, Germ Cell and Embryonal Brain Neoplasms Bone Neoplasms Osteosarcoma Leukopenia Liver Neoplasms Peritoneal Neoplasms Lymphatic Metastasis Recurrence Stomach Neoplasms Germinoma Carcinoma, Squamous Cell Carcinoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Progression Leukemia, Myeloid, Acute Lymphoma Thrombocytopenia Sarcoma Head and Neck Neoplasms Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Retroperitoneal Neoplasms Seminoma Mediastinal Neoplasms Pancreatic Neoplasms Stomatitis Colonic Neoplasms Neoplasms, Second Primary Central Nervous System Neoplasms Hematologic Diseases Leukemia, Myeloid Esophageal Neoplasms Dysgerminoma Rectal Neoplasms Multiple Myeloma Neoplasms, Glandular and Epithelial Nasopharyngeal Neoplasms Mesothelioma Soft Tissue Neoplasms Mucositis Urinary Bladder Neoplasms Medulloblastoma Leukemia Retinal Neoplasms Pleural Neoplasms Lymphoma, B-Cell Vomiting, Anticipatory Fatigue Trophoblastic Neoplasms Cerebellar Neoplasms Glioma Oligodendroglioma Abdominal Neoplasms Glioblastoma Drug-Related Side Effects and Adverse Reactions Carcinoma, Transitional Cell

Chemicals and Drugs84

Antineoplastic Agents Cisplatin Doxorubicin Paclitaxel Cyclophosphamide Antineoplastic Agents, Phytogenic Anti-Bacterial Agents Taxoids Vinblastine Organoplatinum Compounds Naphthyridines Anti-Infective Agents Deoxycytidine Etoposide Antimetabolites, Antineoplastic Camptothecin Fluoroquinolones Methotrexate Surface-Active Agents Carboplatin Ciprofloxacin Ifosfamide Quinolones 4-Quinolones Bleomycin Cephalosporins Lactams Drug Carriers Anthracyclines Antineoplastic Agents, Alkylating Prodrugs Cytarabine Aminoglycosides Antibiotics, Antineoplastic Dacarbazine Carmustine Lomustine Granulocyte Colony-Stimulating Factor Platinum Compounds Melphalan Antiemetics Mitomycin Thiotepa Tumor Markers, Biological Mitoxantrone Tegafur Antibodies, Monoclonal, Humanized Daunorubicin Antifungal Agents beta-Lactamases Bridged Compounds Vindesine Culture Media Antibodies, Monoclonal Platinum Oxonic Acid Receptor, erbB-2 Antibodies, Monoclonal, Murine-Derived Prednisolone Fluorouracil Mesna Nimustine Receptors, Estrogen Granisetron P-Glycoprotein Dexamethasone Tamoxifen Mitomycins Floxuridine Angiogenesis Inhibitors Asparaginase Ondansetron Chlorambucil Antineoplastic Agents, Hormonal Thioguanine 6-Mercaptopurine Biomarkers, Pharmacological Quinazolines Recombinant Proteins Radiopharmaceuticals Fluorodeoxyglucose F18 Altretamine Receptors, Progesterone Idarubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Treatment Outcome Combined Modality Therapy Drug Administration Schedule Microbial Sensitivity Tests Disease-Free Survival Survival Analysis Neoplasm Staging Neoadjuvant Therapy Survival Rate Salvage Therapy Infusions, Intravenous Prognosis Clinical Trials as Topic Drug Evaluation Induction Chemotherapy Drug Delivery Systems Administration, Oral Drug Carriers Chemotherapy, Cancer, Regional Perfusion Follow-Up Studies Transplantation, Autologous Radiotherapy, Adjuvant Radiotherapy Prospective Studies Kaplan-Meier Estimate Infusions, Intra-Arterial Hematopoietic Stem Cell Transplantation Drug Therapy Palliative Care Radiotherapy Dosage Randomized Controlled Trials as Topic Culture Media Chemoradiotherapy Hyperthermia, Induced Maintenance Chemotherapy Remission Induction Multivariate Analysis Cranial Irradiation Clinical Trials, Phase III as Topic Actuarial Analysis Feasibility Studies Bone Marrow Transplantation Proportional Hazards Models Fatal Outcome Mastectomy Drug Therapy, Combination Predictive Value of Tests Tomography, X-Ray Computed Immunohistochemistry Pilot Projects Consolidation Chemotherapy Clinical Trials, Phase II as Topic Risk Factors Hematopoietic Stem Cell Mobilization Treatment Failure Antineoplastic Protocols Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Infusions, Parenteral Immunotherapy Dose Fractionation Positron-Emission Tomography Preoperative Care Karnofsky Performance Status Lymph Node Excision Cystectomy Tumor Burden Chemoradiotherapy, Adjuvant Peripheral Blood Stem Cell Transplantation Random Allocation Cohort Studies

Phenomena and Processes9

Dose-Response Relationship, Drug Time Factors Drug Resistance, Neoplasm Drug Synergism Drug Resistance, Microbial Drug Resistance, Bacterial Apoptosis Drug Resistance, Multiple Gene Expression Regulation, Neoplastic

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science2

Survival Rate Fatal Outcome

Health Care27

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Clinical Trials as Topic Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Palliative Care Randomized Controlled Trials as Topic Multivariate Analysis Clinical Trials, Phase III as Topic Actuarial Analysis Feasibility Studies Proportional Hazards Models Fatal Outcome Predictive Value of Tests Pilot Projects Clinical Trials, Phase II as Topic Risk Factors Treatment Failure Antineoplastic Protocols Age Factors Preoperative Care Karnofsky Performance Status Random Allocation Cohort Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Antineoplastic Agents Cisplatin Treatment Outcome Doxorubicin Combined Modality Therapy Drug Administration Schedule Paclitaxel Microbial Sensitivity Tests Cyclophosphamide Disease-Free Survival Antineoplastic Agents, Phytogenic Survival Analysis Breast Neoplasms Anti-Bacterial Agents Taxoids Lung Neoplasms Neoplasm Staging Vinblastine Neoadjuvant Therapy Survival Rate Organoplatinum Compounds Naphthyridines Anti-Infective Agents Deoxycytidine Neutropenia Etoposide Antimetabolites, Antineoplastic Salvage Therapy Infusions, Intravenous Neoplasms Camptothecin Prognosis Neoplasm Metastasis Clinical Trials as Topic Fluoroquinolones Gram-Positive Bacteria Methotrexate Carcinoma, Non-Small-Cell Lung Drug Evaluation Surface-Active Agents Carboplatin Gram-Negative Bacteria Induction Chemotherapy Dose-Response Relationship, Drug Neoplasm Recurrence, Local Time Factors Drug Delivery Systems Ciprofloxacin Ifosfamide Drug Resistance, Neoplasm Quinolones 4-Quinolones Bleomycin Cephalosporins Drug Synergism Lactams Administration, Oral Drug Carriers Anthracyclines Antineoplastic Agents, Alkylating Chemotherapy, Cancer, Regional Perfusion Prodrugs Cytarabine Follow-Up Studies Bacteria, Anaerobic Cell Line, Tumor Drug Resistance, Microbial Ovarian Neoplasms Testicular Neoplasms Aminoglycosides Vomiting Transplantation, Autologous Adenocarcinoma Nausea Lymphoma, Non-Hodgkin Radiotherapy, Adjuvant Hodgkin Disease Colorectal Neoplasms Radiotherapy Antibiotics, Antineoplastic Dacarbazine Bacteria Prospective Studies Neoplasms, Germ Cell and Embryonal Carmustine Lomustine Granulocyte Colony-Stimulating Factor Kaplan-Meier Estimate Platinum Compounds Brain Neoplasms Bone Neoplasms Infusions, Intra-Arterial Osteosarcoma Melphalan Leukopenia Antiemetics Mitomycin Thiotepa

No FAQ available that match "active agent in chemotherapy"